Literature DB >> 20224468

Posterior uveal melanoma in young patients treated with proton beam therapy.

Demetrios Vavvas1, Ivana Kim, Anne Marie Lane, Alan Chaglassian, Shizuo Mukai, Evangelos Gragoudas.   

Abstract

PURPOSE: The purpose was to study the clinical profile and prognosis of young patients with uveal melanoma treated by proton beam irradiation.
METHODS: A retrospective case-control series was studied. Seventeen patients aged <or=20 years with uveal melanoma and 51 risk factor-matched control subjects aged >20 years were treated for posterior uveal melanoma between 1975 and 2004. All patients were treated with proton beam irradiation at Harvard Cyclotron. Metastasis and survival of patients were the main outcome measures.
RESULTS: Of a total of 3,207 patients with uveal melanoma, 17 patients were <or=20 years of age at the time of diagnosis. No metastatic deaths were observed (median follow-up, 16 years). Among the control group, there were 7 of 50 metastasis-related deaths.
CONCLUSION: There was an excellent outcome regarding metastasis in a cohort of young patients with posterior uveal melanoma treated with proton beam irradiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224468     DOI: 10.1097/IAE.0b013e3181cfdfad

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

Review 1.  Latest developments in the biology and management of uveal melanoma.

Authors:  Sapna P Patel
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.

Authors:  Matthew V Fry; James J Augsburger; Zélia M Corrêa
Journal:  JAMA Ophthalmol       Date:  2019-01-01       Impact factor: 7.389

Review 3.  Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.

Authors:  Natasha M van Poppelen; Daniël P de Bruyn; Tolga Bicer; Rob Verdijk; Nicole Naus; Hanneke Mensink; Dion Paridaens; Annelies de Klein; Erwin Brosens; Emine Kiliҫ
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

4.  Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.

Authors:  Shizhen Lei; Yi Zhang
Journal:  BMC Med Genomics       Date:  2022-03-17       Impact factor: 3.063

5.  Atypical Presentation: Metastatic Uveal Melanoma in a Young Patient without Visual Complaints.

Authors:  Pedro Grachinski Buiar; Sérgio Jobim de Azevedo
Journal:  Front Oncol       Date:  2017-05-18       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.